These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20019615)

  • 1. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
    Tashkin DP
    Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP
    Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T; Samuel S
    Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis.
    Wu Q; Li G; Lei WI; Zhou X
    Respirology; 2009 Jul; 14(5):666-74. PubMed ID: 19402836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tiotropium in the prevention of exacerbations of COPD.
    Anzueto A; Miravitlles M
    Ther Adv Respir Dis; 2009 Jun; 3(3):103-11. PubMed ID: 19617284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
    Singh S; Loke YK; Enright P; Furberg CD
    Thorax; 2013 Jan; 68(1):114-6. PubMed ID: 22764216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The verge and the abyss: tiotropium (Spiriva) in COPD].
    Segel MJ; Ben-Dov I
    Harefuah; 2011 Jan; 150(1):61-3, 66. PubMed ID: 21449160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
    Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Theoretical and clinical aspects of tiotropium application as a first line therapy in stable state of all stages of chronic obstructive pulmonary disease].
    Chazan R
    Pol Merkur Lekarski; 2011 Nov; 31(185):292-8. PubMed ID: 22299532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
    Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA
    COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
    Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
    Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator].
    Izquierdo Alonso JL
    An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.